GA-001(GenAns Biotech)

N/A

Report date: 2025/11/18 10:01:08

Base Information

Drug NameGA-001(GenAns Biotech)
Drug Alias NameGA-001GA001
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRetinitis PigmentosaRetinal DegenerationBlindness
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGenAns Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGenAns Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsRetinitis PigmentosaRetinal DegenerationBlindness
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A